Role of left atrial appendage occlusion in patients with HeartMate 3 |
| |
Authors: | Andrew Melehy,Gillian O’ Connell,Yuming Ning,Paul Kurlansky,Yuji Kaku,Veli Topkara,Melana Yuzefpolskaya,Paolo C Colombo,Gabriel Sayer,Nir Uriel,Yoshifumi Naka,Koji Takeda |
| |
Affiliation: | 1. Department of Surgery, Division of Cardiothoracic and Vascular Surgery, Columbia University Medical Center, New York, NY, USA;2. Department of Surgery, Center of Innovation and Outcomes Research, Columbia University Medical Center, New York, NY, USA;3. Department of Medicine, Division of Cardiology, Columbia University Medical Center, New York, NY, USA |
| |
Abstract: | Open in a separate window OBJECTIVESLeft atrial appendage occlusion (LAAO) at the time of implantation may reduce thromboembolic events (TEs) during continuous-flow left ventricular assist device support. The HeartMate 3 (HM3) reduces TEs overall, but the efficacy of LAAO in HM3 is unknown.METHODSAdults receiving first HM3 implantation from November 2014 through December 2019 at a single, large medical centre were retrospectively reviewed. TEs included device thrombosis and ischaemic stroke. Patients were classified by whether they received LAAO or not. Incidence of TEs was compared between groups using cumulative incidence curves with competing risks (death and heart transplant) and risk factors for TEs were assessed with Fine and Gray competing risk regression.RESULTSA total of 182 patients received HM3, of whom 99 (54%) received LAAO versus 83 (46%) who did not. There were 14 TEs, including 13 strokes (7%) and 1 pump thrombosis (0.5%). No significant difference in the incidence of TEs in each group was found (Gray’s test: P = 0.35). LAAO was not associated with TEs in multivariable Fine–Gray analysis (P = 0.10) and no significant risk factors for TEs were found. There were zero disabling strokes in those who received LAAO compared to 6 (7%) in those who did not receive LAAO (P = 0.008).CONCLUSIONSA low number of TEs was observed in HM3 recipients. LAAO did not further reduce the overall rate of TEs in this patient population, though its use may be beneficial in preventing disabling ischaemic strokes after HM3 implantation. |
| |
Keywords: | Left atrial appendage occlusion HeartMate 3 Mechanical circulatory support Thromboembolism |
|
|